Blockman, MCohen, KDe Waal, RGray, AKredo, TMaartens, GNel, JParrish, ARees, HReubenson, G2025-03-022025-03-022020-05-11Blockman M, Cohen K, De Waal R, Gray A, et al. Azithromycin for COVID-19: evidence review of the clinical benefit and harm. South African National Department of Health, 2020.http://www.health.gov.za/wp-content/uploads/2020/12/Rapid-review-of-Azithromycin-for-COVID-19_11May2020.pdfhttps://hdl.handle.net/11288/598223Azithromycin is used to treat certain bacterial infections, such as bronchitis; pneumonia; sexually transmitted diseases (STD); and infections of the ears, lungs, sinuses, skin, throat, and reproductive organs.enAttribution 3.0 United Stateshttp://creativecommons.org/licenses/by/3.0/us/Macrolide antibioticDrugs and supplementsSARS-CoV-2ZithromaxPharmacokineticsPharmacologyAzithromycinAntibioticCOVID-19Azithromycin for COVID-19: Evidence review of the clinical benefit and harmTechnical Report